gynaecology - Solvay Pharmaceuticals Middle East

Home About Solvay ME Cardiology C.N.S. Gynaecology Gastroenterology Immunology News Cardiology CNS Gynaecology Gastroenterology Immunology Scientific Calendar Teveten Physiotens/Cynt Faverin Betaserc Duphaston Femoston Creon Dicetel Duphalac Duspatalin Pankreoflat Influvac Links Information ME Office Egypt Jordan Lebanon Malta Saudi Arabia Turkey United Arab Emirates Contact us

Meeting Needs in Gynaecology

FOR SOLVAY PHARMACEUTICALS, PEOPLE ARE AT THE HEART OF ALL PROGRESS. THE IMPROVEMENT OF QUALITY OF LIFE OF AN INCREASING NUMBER OF PEOPLE IS AN EXPLICIT COMPONENT OF SOLVAY'S CORE MISSION. THIS COMMITMENT IS SHOWN TO FULL ADVANTAGE IN SOLVAY PHARMA-CEUTICALS PRODUCTS FOR THE TREATMENT OF MENOPAUSAL SYMPTOMS AND COMPLAINTS. WITH A LEADING POSITION IN THE GERMAN MARKET, AND A SECOND POSITION IN EUROPE OVERALL, HORMONE REPLACEMENT THERAPY (HRT) IS DEFINITELY A CORE BUSINESS FOR SOLVAY PHARMACEUTICALS.

The HRT market is developing fast. There is increasing awareness that HRT is very effective and restores the quality of life of many women suffering from menopausal complaints. Long-term HRT reduces their risks for future osteoporosis and cardiovascular disease.

The new oral HRT combination preparation femoston®, first launched in 1995, will give Solvay Pharmaceuticals presence in HRT another boost. femoston® is the only HRT product that contains dydrogesterone - by many regarded as an ideal progestogen for HRT - combined with 17ß -estradiol, which is identical to a woman's most important natural estrogen. The combination of these hormones within one tablet, is a unique aspect of femoston®.
The Solvay HRT portfolio will be further enriched, by new products and presentation forms that are currently in the pipeline.

duphaston® The Leading Progestogen

A perfect example of high-quality progestogen is Solvay's duphaston® (dydrogesterone), the most prescribed progestogen in Western Europe and Middle East area. The unique production process of this synthetic progestogen with pure progestogenic effects requires high standards of production technology.

Supporting The European And North American Menopause Society

The European Menopause Society (EMS) and the North American Menopause Society (NAMS) are non-profit scientific associations, founded with the mission to coordinate the medical and socio-economic use of the results of scientific studies on the menopause. Solvay Pharmaceuticals is one of the original sponsors of both EMS and NAMS. They are supporting the European Society in its tasks of creating synergy by pooling the experiences of the National Societies and spreading knowledge about the menopause.